2011 - CTS-IXA


This page contains exclusive content for the member of the following sections: TTS, CTS, IXA. Log in to view.

SOTA 9- Cell Banking Technologies (Cell Track)

39.540 - Autologous Cord Blood Banking

Presenter: Giuseppe, Mucci, Falciano, San Marino
Authors: Giuseppe Mucci

540

Autologous cordbloodbanking

Giuseppe Mucci

Bioscience Institute, Republic of San Marino

Emerging therapies and regenerative medicine are increasingly focusing on the use of hematopoietic stem cells to treat previously incurable diseases. Main sources of hematopoietic stem cells are BM (Bone Marrow), PB (Peripheral Blood) and CB (Cord Blood). Having a banked and viable source of one’s own stem cells is a real advantage given the current rate of new discoveries and potential new applications under investigation. Today, CB is the easiest way to obtain cells which can be safely banked for at least 23 years, according to latest scientific evidences. In order to preserve this valuable source of stem cells, there are two current options available: to donate to a public bank or to store in a private bank. The first private umbilical cord blood bank was founded in the USA in 1995 and, to date, more than 780,000 units are stored worldwide in more than 130 private banks. In the past years the number of applications of privately stored umbilical cord blood has risen steadily. As of December 2009, there were more than 400 documented therapeutic applications (229 intra-family and 172 autologous). The last successful case reported involved a child of 9 years, who completely recovered from a severe form of acute lymphoblastic leukemia after transplantation of her own CB stem cells at the age of 3. Beyond the accepted and traditional applications for CB stem cells in hematopoietic transplants, new applications are rapidly emerging highlighting an increasing potential of autologous CB in regenerative medicine leading to a new trend focused on more personalized cellular therapies.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada